Literature DB >> 3078288

Cytochrome P-450 and FAD-monooxygenase mediated S- and N-oxygenations.

L A Damani1, A A Houdi.   

Abstract

S- and N-Oxygenations are mostly mediated by either the cytochrome P-450 group of enzymes (haemoproteins), or the FAD-containing monooxygenases (flavoproteins). The nucleophilicity of the heteroatom may be an important determinant of which of these microsomal enzymes is utilised for specific oxygenations. This article describes the approaches that could be used for assessing the relative contribution of these microsomal oxidases to a particular reaction, with reference to studies with N,N-dimethylaniline, diethylsulphide, tetrahydrothiophen and dibenzothiophen.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3078288     DOI: 10.1515/dmdi.1988.6.3-4.235

Source DB:  PubMed          Journal:  Drug Metabol Drug Interact        ISSN: 0792-5077


  4 in total

Review 1.  The role of non-P450 enzymes in drug oxidation.

Authors:  C Beedham
Journal:  Pharm World Sci       Date:  1997-12

Review 2.  Clarifying busulfan metabolism and drug interactions to support new therapeutic drug monitoring strategies: a comprehensive review.

Authors:  Alan L Myers; Jitesh D Kawedia; Richard E Champlin; Mark A Kramer; Yago Nieto; Romi Ghose; Borje S Andersson
Journal:  Expert Opin Drug Metab Toxicol       Date:  2017-08-17       Impact factor: 4.481

3.  Identification of Compounds with Potential Therapeutic Uses from Sweet Pepper (Capsicum annuum L.) Fruits and Their Modulation by Nitric Oxide (NO).

Authors:  Lucía Guevara; María Ángeles Domínguez-Anaya; Alba Ortigosa; Salvador González-Gordo; Caridad Díaz; Francisca Vicente; Francisco J Corpas; José Pérez Del Palacio; José M Palma
Journal:  Int J Mol Sci       Date:  2021-04-25       Impact factor: 5.923

4.  UPLC-Tandem Mass Spectrometry for Quantification of Busulfan in Human Plasma: Application to Therapeutic Drug Monitoring.

Authors:  Kamal M Matar; Salem H Alshemmari; Samar Refaat; Alia Anwar
Journal:  Sci Rep       Date:  2020-06-02       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.